Quick Answer
SERA PROGNOSTICS, INC. reported Research And Development Expense of $13.17 million for the year ending 2025.
- SERA PROGNOSTICS, INC. showed a decrease of -10.6% in Research And Development Expense from 2024 to 2025.
- This data is from SERA PROGNOSTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: $1.75 million | Q3 2020: $1.89 million | Q1 2021: $2.40 million | Q2 2021: $2.82 million | Q3 2021: $2.72 million | Q1 2022: $3.32 million | Q2 2022: $3.26 million | Q3 2022: $4.18 million | Q1 2023: $4.10 million | Q2 2023: $3.69 million | Q3 2023: $3.54 million | Q1 2024: $3.68 million | Q2 2024: $4.41 million | Q3 2024: $3.50 million | Q1 2025: $3.33 million | Q2 2025: $3.34 million | Q3 2025: $3.28 million.
- Over the full 6 years of available data (2020 to 2025), SERA PROGNOSTICS, INC.'s Research And Development Expense has grown by 69.2%.
- Historical annual values: Fiscal year 2025: $13.17 million | Fiscal year 2024: $14.73 million | Fiscal year 2023: $15.23 million | Fiscal year 2022: $14.24 million | Fiscal year 2021: $11.02 million | Fiscal year 2020: $7.78 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: